Widhalm G - Search Results

1

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial.

Bartsch R, Berghoff AS, Furtner J, Marhold M, Bergen ES, Roider-Schur S, Starzer AM, Forstner H, Rottenmanner B, Dieckmann K, Bago-Horvath Z, Haslacher H, Widhalm G, Ilhan-Mutlu A, Minichsdorfer C, Fuereder T, Szekeres T, Oehler L, Gruenberger B, Singer CF, Weltermann A, Puhr R, Preusser M. Bartsch R, et al. Among authors: widhalm g. Nat Med. 2022 Sep;28(9):1840-1847. doi: 10.1038/s41591-022-01935-8. Epub 2022 Aug 8. Nat Med. 2022. PMID: 35941372 Free PMC article. Clinical Trial.

2

Epithelial Growth Factor Receptor Inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study.

Preusser M, Gelpi E, Rottenfusser A, Dieckmann K, Widhalm G, Dietrich W, Bertalanffy A, Prayer D, Hainfellner JA, Marosi C. Preusser M, et al. Among authors: widhalm g. J Neurooncol. 2008 Sep;89(2):211-8. doi: 10.1007/s11060-008-9608-3. Epub 2008 May 6. J Neurooncol. 2008. PMID: 18458820 Clinical Trial.

3

Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression.

Widhalm G, Wolfsberger S, Preusser M, Fischer I, Woehrer A, Wunderer J, Hainfellner JA, Knosp E. Widhalm G, et al. J Neurosurg. 2009 Sep;111(3):563-71. doi: 10.3171/2008.4.17517. J Neurosurg. 2009. PMID: 18991501

4

O(6)-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment?

Widhalm G, Wolfsberger S, Preusser M, Woehrer A, Kotter MR, Czech T, Marosi C, Knosp E. Widhalm G, et al. Cancer. 2009 Mar 1;115(5):1070-80. doi: 10.1002/cncr.24053. Cancer. 2009. PMID: 19156926 Free article. Clinical Trial.

5

Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies.

Widhalm G, Minchev G, Woehrer A, Preusser M, Kiesel B, Furtner J, Mert A, Di Ieva A, Tomanek B, Prayer D, Marosi C, Hainfellner JA, Knosp E, Wolfsberger S. Widhalm G, et al. Neurosurg Rev. 2012 Jul;35(3):381-91; discussion 391. doi: 10.1007/s10143-012-0374-5. Epub 2012 Mar 10. Neurosurg Rev. 2012. PMID: 22407140

6

Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.

Preusser M, Hassler M, Birner P, Rudas M, Acker T, Plate KH, Widhalm G, Knosp E, Breitschopf H, Berger J, Marosi C. Preusser M, et al. Among authors: widhalm g. Clin Neuropathol. 2012 Sep-Oct;31(5):352-60. doi: 10.5414/NP300488. Clin Neuropathol. 2012. PMID: 22541785

7

Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors.

Flechl B, Ackerl M, Sax C, Dieckmann K, Crevenna R, Gaiger A, Widhalm G, Preusser M, Marosi C. Flechl B, et al. Among authors: widhalm g. J Neurooncol. 2012 Sep;109(2):331-9. doi: 10.1007/s11060-012-0897-1. Epub 2012 May 29. J Neurooncol. 2012. PMID: 22644537

8

Strength of skeletal muscle and self-reported physical performance in Austrian glioblastoma-patients.

Keilani M, Krall C, Marosi C, Flechl B, Dieckmann K, Widhalm G, Marhold M, Crevenna R. Keilani M, et al. Among authors: widhalm g. Wien Klin Wochenschr. 2012 Jun;124(11-12):377-83. doi: 10.1007/s00508-012-0186-1. Epub 2012 Jun 12. Wien Klin Wochenschr. 2012. PMID: 22688136 Clinical Trial.

9

Exploratory investigation of eight circulating plasma markers in brain tumor patients.

Ilhan-Mutlu A, Wagner L, Widhalm G, Wöhrer A, Bartsch S, Czech T, Heinzl H, Leutmezer F, Prayer D, Marosi C, Base W, Preusser M. Ilhan-Mutlu A, et al. Among authors: widhalm g. Neurosurg Rev. 2013 Jan;36(1):45-55; discussion 55-6. doi: 10.1007/s10143-012-0401-6. Epub 2012 Jul 5. Neurosurg Rev. 2013. PMID: 22763625

10

Plasma MicroRNA-21 concentration may be a useful biomarker in glioblastoma patients.

Ilhan-Mutlu A, Wagner L, Wöhrer A, Furtner J, Widhalm G, Marosi C, Preusser M. Ilhan-Mutlu A, et al. Among authors: widhalm g. Cancer Invest. 2012 Oct;30(8):615-21. doi: 10.3109/07357907.2012.708071. Epub 2012 Aug 14. Cancer Invest. 2012. PMID: 22891879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page